Nk-1 receptor antagonists to improve anesthesia recovery

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/439 (2006.01) A61P 39/00 (2006.01) A61P 41/00 (2006.01)

Patent

CA 2554823

The present invention is directed to the administration of a compound of the Formula (I)and (Ia), wherein R2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl, to an animal to improve anesthesia recovery

L'invention concerne l'administration, à un animal, d'un composé représenté par les formules (I) et (Ia), dans lesquelles R?2¿ est sélectionné dans le groupe constitué par méthyle, éthyle, isopropyle, sec-butyle et tert-butyle, en vue d'améliorer la récupération consécutive à une anesthésie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nk-1 receptor antagonists to improve anesthesia recovery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nk-1 receptor antagonists to improve anesthesia recovery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nk-1 receptor antagonists to improve anesthesia recovery will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1556568

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.